partnership is only good long term (3 plus years out) and that shouldn't lift the price much higher than in the teens . having to share in the revenue is a detractor. thats also if the drug they're partnering with avoids all the hurdles. so, no affect near term, with reinforced short interest?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.